Gender identity is the intrinsic perception of a person to be a man, woman or some gender alternative. Transgender people feel that they are in the wrong body, since they feel the opposite sex to the assigned. When this incongruence between gender identity and the physical phenotype generates great anguish, anxiety and persistent discomfort, it is called gender dysphoria. It is estimated that 0.4% -1.3% of the world population experience different degrees of Gender Dysphoria. (3), and not all people with gender dysphoria have the same needs, so the evaluation of the personal goal to achieve well-being is very important. All medical interventions involve risks, so the understanding of the latter, adherence and management by trained professionals minimizes them. In the Journal of the Chilean Society of Obstetrics and Child and Adolescent Gynecology, we have recently published two review articles on the introduction to Hormonotherapy in transgender people, objectives of therapy, transition in adolescence, and the male to female transition, so this writing will focus only on the Risks of Hormonal Therapy in the transition.
|Translated title of the contribution||Hormonal therapy in transgender people according to the World Professional Association for Transgender Health (WPATH) and clinical guidelines of the Endocrine Society|
|Number of pages||16|
|Journal||Revista Chilena de Obstetricia y Ginecologia|
|Publication status||Published - 1 Sept 2018|
ASJC Scopus subject areas
- Obstetrics and Gynaecology